MLAB vs NOW: fair value comparison
Mesa Laboratories, Inc. and ServiceNow, Inc. · Updated 2026-10-19
NOW is still awaiting a full valuation verdict under our six-validated-windows standard. Within Technology, MLAB currently ranks higher by quality score.
| MLAB | NOW | |
|---|---|---|
| Verdict | Undervalued | Awaiting full valuation |
| Last price | $122.48 | $140.86 |
| 12-month range | $70.60–$142.23 | $83.00–$189.26 |
| Rank by discount to fair value | #82 of 181 Technology | — |
| Rank by quality score | #111 of 274 Technology | #113 of 274 Technology |
| Quality grade | B | B |
| Leverage | Moderate | Moderate |
| Margin trend | Expanding | Contracting |
| Revenue growth | Modest | Strong |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Uptrend | — |
| DCF cross-check | Overvalued | Overvalued |
| 52-week position | The upper-middle quarter | The upper-middle quarter |
Full single-stock breakdowns: MLAB fair value analysis · NOW fair value analysis